← All stocks

ACADIA PHARMACEUTICALS INC

ACAD Net selling
CIK 0001070494 #1355 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$3.40M
$297.91K on a plan · $694.81K straight out of an exercise
Sold at will
$2.41M
18 of 24 sales
Net
−$3.40M
−$2.41M against sales at will

By person

14 insiders · 24 transactions
0.4×

Catherine Owen holds only 0.4 times base salary in stock. $434.28K of shares against $930.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Catherine Owen last reported holding, valued at $29.34, the price Common Stock was last bought or sold at on the open market here, on 6 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
$1.13M (9) scheduled
−$1.13M
67,828
0.0394%
$1.99M
+44.0%
Daly James M
Director
$670.98K (1)
−$670.98K
12,148
0.0071%
$356.39K
−50.7%
Kihara James
PRINCIPAL ACCOUNTING OFFICER
$602.84K (8) scheduled
−$602.84K
13,088
0.0076%
$383.97K
−29.1%
Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
$506.41K (3)
−$506.41K
18,994
0.0110%
$557.24K
Owen Adams Catherine
Chief Executive Officer
$249.93K (1)
−$249.93K
14,803
0.0086%
$434.28K
+404.4%
Rhodes Jennifer J
EVP, CHIEF LEGAL OFFICER, SEC
$245.02K (2)
−$245.02K
11,280
0.0065%
$330.93K
+598.5%
BAKER BROS. ADVISORS LP entity
Director
39,384,587
22.86%
$1.16B
+0.2%
Teehan Brendan
EVP, COO, HEAD OF COMMERCIAL
62,105
0.0360%
$1.82M
+18.1%
SOLAND DANIEL B
Director
44,041
0.0256%
$1.29M
+27.1%
HARRIGAN EDMUND
Director
43,148
0.0250%
$1.27M
+68.2%
GAROFALO ELIZABETH A.
Director
33,489
0.0194%
$982.48K
+48.7%
Ndu Adora
Director
32,908
0.0191%
$965.44K
+198.3%
Brege Laura
Director
23,202
0.0135%
$680.69K
+15.1%
Poole Jonathan
Director
2,010
0.0012%
$58.97K
Insider
Date
Role
Action
Shares
Price
Amount
Kihara James
26 Jun 2026
PRINCIPAL ACCOUNTING OFFICER
Sold on a plan
11,421
$26.08
$297.91K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 5
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 245,425
History held since 14 Nov 2016